Latest news
US FDA approves Replimune's skin cancer drug after prior rejections - ET PharmaET Pharma · Mon, 10 Aug 2026 11:03:17 GMTAydah AlAwadhi: 385 Cancer Drug Approvals – Are We Trading Strong Evidence for Speed? - OncodailyOncodaily · Sat, 08 Aug 2026 23:48:09 GMTRecovery for Replimune: Accelerated Approval for Cancer Drug Twice Spurned by FDA - MedCity NewsMedCity News · Fri, 07 Aug 2026 22:12:34 GMTReplimune Wins FDA Skin Cancer Drug Approval on Third Try. Why the Stock Is Tumbling. - Barron'sBarron's · Fri, 07 Aug 2026 19:33:00 GMTKalshi and Polymarket bets on clinical trials criticized as 'ghastly' - npr.orgnpr.org · Fri, 07 Aug 2026 10:00:00 GMT‘Concerning’ Trends in Cancer Drug Approvals - MedscapeMedscape · Fri, 07 Aug 2026 09:40:52 GMTVepdegestrant (Veppanu) Approved by FDA - Breast Cancer.orgBreast Cancer.org · Tue, 04 Aug 2026 07:00:00 GMTFDA Fast Track and Priority Review Designations Granted in July 2026 - Oncology News CentralOncology News Central · Mon, 03 Aug 2026 13:59:35 GMT